OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?
Alina Scridon, Alkora Ioana Balan
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1599-1599
Open Access | Times Cited: 14

Showing 14 citing articles:

Microneedle Patch Loaded with Exosomes Containing MicroRNA‐29b Prevents Cardiac Fibrosis after Myocardial Infarction
Jian‐Ping Yuan, Hong Yang, Chunxia Liu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 88

The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization
Kasper Favere, Manon Van Hecke, Sander Eens, et al.
Cardiovascular Pathology (2024) Vol. 72, pp. 107652-107652
Open Access | Times Cited: 5

Regulatory mechanism of CaMKII δ mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872
Jingjing Zhang, Ji Cao, Jianan Qian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115380-115380
Open Access | Times Cited: 10

Chinese and western medicine treatment of myocardial fibrosis drugs
Yuxi Zhu, Fangmei Zhang, Zhongcheng Li, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access

Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
Milena Paw, Agnieszka A. Kusiak, Kinga Nit, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8

Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Inês Falcão‐Pires, Ana Filipa Ferreira, Fábio Trindade, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1454-1479
Open Access | Times Cited: 3

The interplay between doxorubicin chemotherapy, antioxidant system, and cardiotoxicity: Unrevealing of the protective potential of tannic acid
Guldemet Kansu, Neslihan Öztürk, Medine Sibel Karağaç, et al.
Biotechnology and Applied Biochemistry (2024)
Open Access | Times Cited: 1

Autonomic imbalance and atrial ectopic activity—a pathophysiological and clinical view
Alina Scridon
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 4

Role of magnetic resonance imaging in the detection of myocardial fibrosis in life-threatening ventricular arrhythmias
В. Э. Олейников, E. V. Averyanova, A. V. Vdovkin, et al.
Russian Journal of Cardiology (2023) Vol. 28, Iss. 7, pp. 5476-5476
Open Access | Times Cited: 1

Exogenous ECM in an environmentally-mediatedin vitromodel for cardiac fibrosis
Natalie Pachter, Kristen E. Allen, Tracy A. Hookway
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

3D Spheroids — a Cellular Model for Studying the Effects of Hypoxia on the Epicardial Microenvironment
К. В. Дергилев, З. И. Цоколаева, И. Б. Белоглазова, et al.
General Reanimatology (2023) Vol. 19, Iss. 1, pp. 43-49
Open Access

NEW BIOLOGICAL MARKERS FOR A PROGNOSTIC MODEL FOR ASSESSING THE RISK OF CARDIAC FIBROSIS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
T. B. Pecherina, В. Н. Каретникова, В. В. Кашталап, et al.
Complex Issues of Cardiovascular Diseases (2023) Vol. 12, Iss. 4, pp. 188-199
Open Access

Page 1

Scroll to top